video thumbnail

Mechanism of Opioid Induced Analgesia (Pain Part 6)

Duration: 27:19

Write A New Comment

1 Comments

...

kakavand@*.com

Jan 17 2024, 7:44 pm

Please give me the CMEs. Thank you.

...

mobeen@*.com

Jan 23 2024, 3:40 pm

CMEs are enabled now. Please click the button above and take the test and survey.

...

kakavand@*.com

Jan 23 2024, 3:40 pm

thank you very much.

...

mobeen@*.com

Jan 23 2024, 3:40 pm

Pleasure.

We will discuss the effects of systemic administration of opioids by their actions on the brain, spinal cord, and in some instances periphery. The following topics will be covered:
1. Supraspinal actions.
2. Spinal opioid actions.
3. Peripheral actions.
4. Neurotransmitters released in the supraspinal and spinal pathways.
 

Mood Alterations and Rewarding Properties
Reference: Brunton, Laurence; Knollman, Bjorn; Hilal-Dandan, Randa. Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th Edition (Goodman and Gilman's the Pharmacological Basis of Therapeutics) (p. 1376). McGraw Hill LLC. Kindle Edition.

* Recognize opioid mechanisms in pain modulation at supraspinal, spinal, and peripheral levels.

* Identify the pivotal role of Mesencephalic Periaqueductal Gray (PAG) in supraspinal opioid analgesia.

* Analyze the clinical implications of opioid-induced disinhibition of the medullospinal tract.

* Explore the effects of opioids at spinal levels, encompassing calcium channel modulation, neurotransmitter release, and hyperpolarization.

*Recognize direct opioid effects on peripheral pain thresholds.

Following answers are created by ChatGPT. Occasionally the answer may be harmful, incorrect, false, misleading, incomplete, or limited in knowledge of world. Please contact your doctor for all healthcare decisions. Also, double check the answer provided by the AI below.

Faculty

In addition to the presenter, following authors may have helped with the content writing, review, or approval:

CME, CE, CEU and Other Credit Types:

ACCME Accreditation Statement
The DrBeen Corp is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement
The DrBeen Corp designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Disclosure Information

In accordance with the disclosure policies of DrBeen Corp and the ACCME (Accreditation Council for Continuing Medical Education), we are committed to upholding principles of balance, independence, objectivity, and scientific rigor in all of our Continuing Medical Education (CME) and Continuing Education (CE) activities. These policies include the careful management and mitigation of any relevant financial relationships with organizations that are not eligible.
All members of the Activity Planning Committee and presenters have disclosed their relevant financial relationships. The DrBeen Corp CE Committee has thoroughly reviewed these disclosures and determined that these relationships are not deemed inappropriate in the context of their respective presentations. Additionally, they are found to be consistent with the educational objectives and the integrity of the activity.

Faculty Disclosures
Author declares no conflict of interest.

Please login to access this content.

Don't have an account?

See Plans

Instructors

DEA Requirement for Opioid Use Disorder Management

Related Videos